The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Revance Therapeutics, Inc. (RVNC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

3.5700

-0.0900

(-2.46%)

At close: 04:00PM EDT

3.7100

+0.14

(+3.92%)

After hours:

05:10PM EDT

Currency in USD

Earnings estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	4	4	5	5
Avg. Estimate	-0.75	-0.51	-2.3	-1.06
Low estimate	-1.19	-0.56	-3.24	-1.22
High estimate	-0.5	-0.46	-1.61	-0.78
Year ago EPS	-0.74	-0.8	-3.83	-2.3

Revenue estimate	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
No. of analysts	7	7	10	10
Avg. Estimate	56.63M	68.21M	281.72M	382.52M
Low estimate	53.47M	64M	272.88M	341M
High estimate	59.6M	72.83M	288M	406.96M
Year ago sales	49.33M	58.13M	234.04M	281.72M
Sales growth (year/est)	14.80%	17.30%	20.40%	35.80%

Earnings history	30/03/2023	29/06/2023	29/09/2023	30/12/2023
Est. EPS	-0.7	-0.78	-0.85	-0.72
Actual EPS	-0.74	-0.8	-1.63	-0.62
Difference	-0.04	-0.02	-0.78	0.1
Surprise %	-5.70%	-2.60%	-91.80%	13.90%

EPS trend	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Current estimate	-0.75	-0.51	-2.3	-1.06
7 days ago	-0.75	-0.51	-2.3	-1.06
30 days ago	-0.75	-0.51	-2.3	-1.06
60 days ago	-0.61	-0.47	-1.9	-0.91
90 days ago	-0.59	-0.44	-1.79	-0.69

EPS revisions	Current qtr. (Mar 2024)	Next qtr. (Jun 2024)	Current year (2024)	Next year (2025)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	1	1	1	1
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	1

Growth estimates	RVNC	Industry	Sector(s)	S&P 500
Current qtr.	-1.40%	N/A	N/A	N/A
Next qtr.	36.30%	N/A	N/A	N/A
Current year	39.90%	N/A	N/A	N/A
Next year	53.90%	N/A	N/A	N/A
Next 5 years (per annum)	11.60%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A